--- title: "Ainos | 8-K: FY2026 Q1 Revenue: USD 161" type: "News" locale: "en" url: "https://longbridge.com/en/news/286314063.md" datetime: "2026-05-13T20:36:22.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/286314063.md) - [en](https://longbridge.com/en/news/286314063.md) - [zh-HK](https://longbridge.com/zh-HK/news/286314063.md) --- # Ainos | 8-K: FY2026 Q1 Revenue: USD 161 Revenue: As of FY2026 Q1, the actual value is USD 161. EBIT: As of FY2026 Q1, the actual value is USD -2.107 M. Ainos, Inc. reported its financial results for the first quarter ended March 31, 2026, indicating a continued transition towards industrial and infrastructure-focused AI Nose deployments . #### Revenue Revenues for the first quarter of 2026 were $161, a decrease from $106,207 in the first quarter of 2025 . #### Gross Profit (Loss) The company reported a gross loss of -$602 for the first quarter of 2026, compared to a gross profit of $87,974 for the same period in 2025 . Cost of revenues was -$763 in Q1 2026, compared to -$18,233 in Q1 2025 . #### Operating Expenses Total operating expenses for the first quarter of 2026 were $2,283,045, a decline of approximately 30% year-over-year from $3,250,845 in the first quarter of 2025 . Research and development expenses were $1,689,860 in Q1 2026, down from $1,724,084 in Q1 2025 . Selling, general and administrative expenses decreased to $593,185 in Q1 2026 from $1,526,761 in Q1 2025 . #### Loss from Operations Loss from operations was -$2,283,647 for the first quarter of 2026, an improvement from -$3,162,871 in the first quarter of 2025 . #### Non-Operating Expenses, Net Total non-operating expenses, net, were -$176,153 in Q1 2026, compared to -$123,151 in Q1 2025 . Interest expense was -$176,876 in Q1 2026, compared to -$180,445 in Q1 2025 . Other income, net, was $723 in Q1 2026, compared to $57,294 in Q1 2025 . #### Net Loss Net loss before income taxes was -$2,459,800 for the first quarter of 2026, an improvement from -$3,286,022 in the first quarter of 2025 . The net loss for the first quarter of 2026 was -$2,459,800, compared to -$3,286,022 for the first quarter of 2025 . #### Balance Sheet Highlights (as of March 31, 2026) Cash and cash equivalents increased to $2,841,422 as of March 31, 2026, from $417,353 as of December 31, 2025 . Total current assets were $3,519,615 as of March 31, 2026, up from $1,138,799 as of December 31, 2025 . Total assets amounted to $22,081,583 as of March 31, 2026, compared to $20,871,108 as of December 31, 2025 . Total current liabilities were $6,346,479 as of March 31, 2026, significantly higher than $1,078,683 as of December 31, 2025, partly due to new convertible notes payable and loan payable to related parties . Total liabilities were $16,389,637 as of March 31, 2026, compared to $13,308,526 as of December 31, 2025 . Total stockholders’ equity was $5,691,946 as of March 31, 2026, down from $7,562,582 as of December 31, 2025 . The company strengthened its balance sheet and liquidity position through a previously announced NT$90 million (approximately US$2.8 million) financing arrangement . #### Operational Metrics and Strategic Initiatives Ainos, Inc. continued deployment activities for an approximately three-year, $2.1 million AI Nose commercial arrangement in backend semiconductor manufacturing environments, targeting about 1400 AI Nose systems . Pilot and validation activities were initiated in selected front-end semiconductor environments . The company expanded industrial commercialization initiatives through a distribution partnership for front-end semiconductor opportunities . AI Nose deployment expanded into healthcare infrastructure settings, including hospital utility systems, laboratory environments, HVAC-related monitoring, MRI-related environments, and critical infrastructure safety applications . Development of Smell ID datasets and Smell Language Model capabilities continued through deployment and pilot activities . Optimization of AI Nose’s near-threshold sensing and pattern-recognition capabilities is ongoing, supporting earlier identification of environmental anomalies . #### Outlook Ainos, Inc. anticipates that its current execution priorities will facilitate broader revenue generation opportunities in the second half of 2026 . The company is focused on execution, deployment readiness, Smell ID dataset expansion, and Smell Language Model development . These efforts support the long-term objective of advancing AI Nose as a scalable Smell AI platform for real-world infrastructure environments . ### Related Stocks - [AIMD.US](https://longbridge.com/en/quote/AIMD.US.md) ## Related News & Research - [Ainos, Inc. Announces Long-Term SmellTech Platform Strategy](https://longbridge.com/en/news/271521393.md) - [What's Going On With eBay Stock Tuesday?](https://longbridge.com/en/news/286091849.md) - [HPE to Present Live Audio Webcast of Fiscal 2026 Second Quarter Earnings Conference Call | HPE Stock News](https://longbridge.com/en/news/285935495.md) - [Ainos Articulates Its Platform Strategy to Digitize Smell as the Next Native AI Data Language | AIMD Stock News](https://longbridge.com/en/news/271336539.md) - [Options Exercise Update At Electronic Arts: Jeff Huber Engages, Resulting In $-30](https://longbridge.com/en/news/285229132.md)